Medical Science Liaison, South Atlantic

Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases.

We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients.

It is an exciting time of growth for argenx as we strive to achieve our VISION 2030. Vision 2030 is our long-term commitment to transform the treatment of autoimmune diseases by strengthening our leadership in neonatal Fc receptor (FcRn) biology, investing in our continuous pipeline of differentiated antibody candidates, and scaling in a disciplined way to ensure innovation remains core to the argenx mission. Vision 2030 includes the following goals : 50,000 patients globally on treatment with an argenx medicine, 10 labeled indications across all approved assets, including VYVGART and potentially empasiprubart and ARGX-119 and five new molecules in Phase 3 development.

The Medical Science Liaison (MSL), a field-based extension of the Medical Affairs team, is an expert on argenxs scientific data, products and trials, and is responsible for engagement with Key Opinion Leaders at academic and community centers, including potential and confirmed clinical research sites.

• The MSL will represent and reflect argenxs values as a science-driven, patient-centric organization developing innovative medicines for patients and always upholding the highest ethical standards
• The MSL will support KOL development and advocacy while serving as a strategic field partner with cross-functional colleagues
• The MSL is critical in understanding the management of diseases of interest, mapping the patient journey, identifying unmet medical needs and data gaps and gathering and sharing insights to enhance patient care
• The MSL will identify clinical trial sites and opportunities for research, work closely with clinical development colleagues to coordinate with external stakeholders, support execution of clinical studies and build productive collaborations

This position is remote and will cover the following territory : South Atlantic (North Carolina and Eastern Virginia)

Roles and Responsibilities :

Develop and continuously maintain the highest scientific and medical expertise of all relevant diseases, products, development plans, and be acknowledged internally and externally as an expert

Ensure timely and informative scientific / medical exchanges with external stakeholders that accurately reflect scientific data and research objectives

Identify potential investigators and centers for participation in clinical research, support feasibility assessments and site initiation, and develop and maintain productive collaborations

Ensure a close working relationship with all argenx functions, including cross-functional field partners

Skills and Competencies :

Education, Experience and Qualifications :

LI-Remote

At argenx, all applicants are welcomed in an inclusive environment. They will receive equal consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other applicable legally protected characteristics. argenx is proud to be an equal opportunity employer.

If you require reasonable accommodation in completing your application, interviewing, or otherwise participating in the candidate selection process please contact us at hr.us@argenx.com. Only inquiries related to an accommodation request will receive a response.

PDN-9e28d3dd-92bb-4c6d-b18c-eb6a3bb51dd5